PDL guidance

Share this: Email | Facebook | X

PDL BioPharma Inc. of Incline Village, the owner of a portfolio of royalty interest on biopharmaceutical patents, says it expects third quarter revenue of $165 million. This compares with $100.2 million in the third quarter of last year.

Comments

Use the comment form below to begin a discussion about this content.

Sign in to comment